| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.02B | +22.4% |
| Cost of Revenue | $159.4M | -17.1% |
| R&D Expense | $79.0M | +3.5% |
| SG&A Expense | $154.3M | +3.5% |
| Operating Income | $551.5M | +63.4% |
| Pre-tax Income | $557.1M | +59.9% |
| Income Tax | $113.0M | +69.4% |
| Net Income | $444.1M | +57.7% |
| EPS (Basic) | $3.50 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $115.8M | -2.1% |
| Accounts Receivable | $288.2M | +23.6% |
| Inventory | $141.9M | +11.2% |
| Current Assets | $1.09B | +45.4% |
| Total Assets | $2.06B | +19.1% |
| Current Liabilities | $139.1M | +23.7% |
| Long-term Debt | $1.51B | +0.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $479.1M | +23.3% |
| Capital Expenditures | $10.7M | -30.1% |
| Investing Cash Flow | -$262.7M | -171.1% |
| Financing Cash Flow | -$218.9M | +46.4% |
| Free Cash Flow | $468.4M | +25.5% |
| +64.3% |
| EPS (Diluted) | $3.43 | +63.3% |
| Total Liabilities |
| $1.70B |
| +3.0% |
| Stockholders' Equity | $363.8M | +334.1% |